Total planned funding: $115,363,232
Allocations
Countries/Regions
India | $115,363,232 |
Organizational Types
Unknown | $60,136,962 |
NGO | $21,702,610 |
Own Agency | $20,323,660 |
University | $3,450,000 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,200,000 |
FBO | $2,200,000 |
Private Contractor | $1,650,000 |
Host Country Government Agency | $600,000 |
Program Areas
Governance and Systems | $44,497,117 |
Prevention | $29,418,231 |
Management and Operations | $15,137,528 |
Care | $14,757,291 |
Treatment | $5,913,945 |
Testing | $5,639,120 |
Budget Codes
OHSS: Health Systems Strengthening | $23,535,961 |
HVMS: Management and Operations | $15,137,528 |
HVSI: Strategic Information | $14,864,516 |
HVOP: Sexual Prevention: Other Sexual Prevention | $14,811,793 |
HBHC: Care: Adult Care and Support | $8,680,878 |
HLAB: Laboratory Infrastructure | $6,096,640 |
HVCT: Testing: HIV Testing and Counseling | $5,639,120 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $5,458,074 |
HTXS: Treatment: Adult Treatment | $5,307,544 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,423,004 |
HVTB: Care: TB/HIV | $3,055,805 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $2,855,524 |
HKID: Care: Orphans and Vulnerable Children | $2,817,879 |
HMBL: Biomedical Prevention: Blood Safety | $1,869,836 |
PDTX: Treatment: Pediatric Treatment | $582,924 |
PDCS: Care: Pediatric Care and Support | $202,729 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$60,136,962
Countries/Regions
USG Aggregated Agencies:
$15,207,623
Countries/Regions
FHI 360:
$13,737,357
Countries/Regions
University of Washington:
$3,450,000
Countries/Regions